Data as of 4:03pm ET
| +0.13 / +0.37%|
The 29 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 35.69, with a high estimate of 46.73 and a low estimate of 26.76. The median estimate represents a +2.48% increase from the last price of 34.83.
The current consensus among 33 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.